Related references
Note: Only part of the references are listed.A novel immunodiagnosis panel for hepatocellular carcinoma based on bioinformatics and the autoantibody-antigen system
Jinyu Wu et al.
CANCER SCIENCE (2022)
Somatic mutation and expression of BAP1 in hepatocellular carcinoma: an indicator for ferroptosis and immune checkpoint inhibitor therapies
Yu-Chuan Yan et al.
JOURNAL OF CANCER (2022)
X-Linked Tumor Suppressor Genes Act as Presumed Contributors in the Sex Chromosome-Autosome Crosstalk in Cancers
Bhanupriya Dhabhai et al.
CANCER INVESTIGATION (2022)
Epigenetic Regulatory Enzymes: mutation Prevalence and Coexistence in Cancers
Amit Sharma et al.
CANCER INVESTIGATION (2021)
30 years of CIK cell therapy: recapitulating the key breakthroughs and future perspective
Amit Sharma et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)
Long non-coding RNA MAPKAPK5-AS1/PLAGL2/HIF-1α signaling loop promotes hepatocellular carcinoma progression
Liang Wang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)
Immunoautophagy-Related Long Noncoding RNA (IAR-lncRNA) Signature Predicts Survival in Hepatocellular Carcinoma
Yulu Wang et al.
BIOLOGY-BASEL (2021)
Immunotherapy for Hepatocellular Carcinoma: Current Limits and Prospects
Cheng Zhong et al.
FRONTIERS IN ONCOLOGY (2021)
ATE1 Inhibits Liver Cancer Progression through RGS5-Mediated Suppression of Wnt/β-Catenin Signaling
Cong Xu et al.
MOLECULAR CANCER RESEARCH (2021)
Novel oncogenes and tumor suppressor genes in hepatocellular carcinoma
Fang Wang et al.
LIVER RESEARCH (2021)
LncRNA BCYRN1/miR-490-3p/POU3F2, served as a ceRNA network, is connected with worse survival rate of hepatocellular carcinoma patients and promotes tumor cell growth and metastasis
Shichao Ding et al.
CANCER CELL INTERNATIONAL (2020)
Molecular Signaling Pathways and Therapeutic Targets in Hepatocellular Carcinoma
Manali Dimri et al.
CANCERS (2020)
Biomarkers in Hepatocellular Carcinoma: Diagnosis, Prognosis and Treatment Response Assessment
Federico Pinero et al.
CELLS (2020)
Ubiquitin Carboxyl-Terminal Hydrolases (UCHs): Potential Mediators for Cancer and Neurodegeneration
Amit Sharma et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Prognostic gene expression signature revealed the involvement of mutational pathways in cancer genome
Hongde Liu et al.
JOURNAL OF CANCER (2020)
The lncRNA MIR4435-2HG is upregulated in hepatocellular carcinoma and promotes cancer cell proliferation by upregulating miRNA-487a
Qinglei Kong et al.
CELLULAR & MOLECULAR BIOLOGY LETTERS (2019)
Hepatocellular Carcinoma
Augusto Villanueva
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Regulator of G protein signaling 20 promotes proliferation and migration in bladder cancer via NF-κB signaling
Gang Li et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
y Long non-coding RNA Linc00483 accelerated tumorigenesis of cervical cancer by regulating miR-508-3p/RGS17 axis
Pin Hu et al.
LIFE SCIENCES (2019)
Mutational Landscape of the BAP1 Locus Reveals an Intrinsic Control to Regulate the miRNA Network and the Binding of Protein Complexes in Uveal Melanoma
Amit Sharma et al.
CANCERS (2019)
MicroRNA-199 suppresses cell proliferation, migration and invasion by downregulating RGS17 in hepatocellular carcinoma
Wei Zhang et al.
GENE (2018)
Emerging Roles of G Protein-Coupled Receptors in Hepatocellular Carcinoma
Wen-Ting Peng et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
lncRNA NEAT1 promotes cell proliferation and invasion by regulating miR-365/RGS20 in oral squamous cell carcinoma
Gang Huang et al.
ONCOLOGY REPORTS (2018)
The noncoding RNA HOXD-AS1 is a critical regulator of the metastasis and apoptosis phenotype in human hepatocellular carcinoma
Shan Lu et al.
MOLECULAR CANCER (2017)
Regulator of G‑protein signaling 5 enhances portal vein invasion in hepatocellular carcinoma
Yumi Umeno et al.
Oncology Letters (2017)
Long noncoding RNA PVT1 promotes hepatocellular carcinoma progression through regulating miR-214
Xun Gou et al.
CANCER BIOMARKERS (2017)
Regulator of G protein signaling 20 correlates with clinicopathological features and prognosis in triple-negative breast cancer
Quan Li et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Regulator of G protein signaling 20 enhances cancer cell aggregation, migration, invasion and adhesion
Lei Yang et al.
CELLULAR SIGNALLING (2016)
Regulator of G protein signaling 19 suppresses Ras-induced neoplastic transformation and tumorigenesis
Yingchun Wang et al.
CANCER LETTERS (2013)
Over-expression of regulator of G protein signaling 5 promotes tumor metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma cells
Minghua Hu et al.
JOURNAL OF SURGICAL ONCOLOGY (2013)
Predicting RNA-Protein Interactions Using Only Sequence Information
Usha K. Muppirala et al.
BMC BIOINFORMATICS (2011)
RGS19 stimulates cell proliferation by deregulating cell cycle control and enhancing Akt signaling
Prudence H. Tso et al.
CANCER LETTERS (2011)
Altered expression and function of regulator of G-protein signaling-17 (RGS17) in hepatocellular carcinoma
Eugene Sokolov et al.
CELLULAR SIGNALLING (2011)
RGS17, an Overexpressed Gene in Human Lung and Prostate Cancer, Induces Tumor Cell Proliferation Through the Cyclic AMP-PKA-CREB Pathway
Michael A. James et al.
CANCER RESEARCH (2009)
RGS16 Inhibits Breast Cancer Cell Growth by Mitigating Phosphatidylinositol 3-Kinase Signaling
Genqing Liang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Share Paper
